Analystreport

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) was downgraded by analysts at Goldman Sachs Group Inc from a "neutral" rating to a "sell" rating. They now have a $128.00 price target on the stock...

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com